TR199903211T2 - Solutions containing azasteroids. - Google Patents
Solutions containing azasteroids.Info
- Publication number
- TR199903211T2 TR199903211T2 TR1999/03211T TR9903211T TR199903211T2 TR 199903211 T2 TR199903211 T2 TR 199903211T2 TR 1999/03211 T TR1999/03211 T TR 1999/03211T TR 9903211 T TR9903211 T TR 9903211T TR 199903211 T2 TR199903211 T2 TR 199903211T2
- Authority
- TR
- Turkey
- Prior art keywords
- present
- azasteroids
- solutions containing
- invention describes
- another aspect
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Abstract
Mevcut bulus, farmasötik olarak aktif aza steroit, polietilen glikol, ve propilen glikolün tedavi edici olarak etkili bir miktarini içeren yeni bir çözeltiyi tarif etmektedir. Baska bir yönden, mevcut bulus, bulusun çözeltisini içeren bir farmasötik bilesimi tarif etmektedir. Baska bir yönden, mevcut bulus mevcut bulusun bilesimi ile doldurulmus bir jelatin kapsülü tarif etmektedir.The present invention describes a new solution containing a therapeutically effective amount of pharmaceutically active steroids, polyethylene glycol, and propylene glycol. In another aspect, the present invention describes a pharmaceutical composition comprising the solution of the invention. In another aspect, the present invention describes a gelatin capsule filled with the composition of the present invention.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9717444.5A GB9717444D0 (en) | 1997-08-19 | 1997-08-19 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199903211T2 true TR199903211T2 (en) | 2000-04-21 |
Family
ID=10817633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR1999/03211T TR199903211T2 (en) | 1997-08-19 | 1998-08-17 | Solutions containing azasteroids. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1005346A2 (en) |
JP (1) | JP2002511100A (en) |
KR (1) | KR20010014079A (en) |
CN (1) | CN1263466A (en) |
AU (1) | AU8979698A (en) |
BR (1) | BR9810285A (en) |
CA (1) | CA2295023A1 (en) |
GB (1) | GB9717444D0 (en) |
TR (1) | TR199903211T2 (en) |
WO (1) | WO1999008684A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IS6633A (en) * | 2002-11-22 | 2004-05-23 | Omega Farma Ehf. | Compositions of finasteride tablets |
CZ300438B6 (en) * | 2003-11-25 | 2009-05-20 | Pliva Hrvatska D.O.O. | Process for preparing solid medicament form for oral administration with instantaneous release of active substance and containing as the active substance finasteride polymorphous form |
WO2005066195A1 (en) * | 2004-01-02 | 2005-07-21 | Pharmacon Forschung Und Beratung Gmbh | Method for producing 1,2-unsaturated azasteroids |
EP2050436A1 (en) | 2007-12-21 | 2009-04-22 | Siegfried Generics International AG | Pharmaceutical composition containing dutasteride |
DE102008059201A1 (en) * | 2008-11-27 | 2010-06-02 | GÖPFERICH, Achim, Prof. Dr. | In situ precipitating drug solutions |
KR101055412B1 (en) * | 2010-11-19 | 2011-08-08 | (주)비씨월드제약 | Composition for self-emulsifying preparation comprising dutasteride and manufacturing process thereof |
CN103169712B (en) * | 2011-12-20 | 2017-10-27 | 重庆华邦制药有限公司 | Improve dutasteride's preparation of bioavilability and preparation method thereof |
JP2015516441A (en) * | 2012-05-18 | 2015-06-11 | ルオダ ファーマ ピーティーワイ リミテッド | Liquid formulation |
CN103479595B (en) * | 2012-06-13 | 2015-08-26 | 成都国弘医药有限公司 | A kind of soft capsule containing dutasteride |
WO2014002015A1 (en) | 2012-06-25 | 2014-01-03 | Ranbaxy Laboratories Limited | Pharmaceutical composition comprising dutasteride |
CN103830201A (en) * | 2012-11-20 | 2014-06-04 | 重庆医药工业研究院有限责任公司 | Dutasteride liquid soft capsules |
ES2555485T1 (en) | 2014-05-26 | 2016-01-04 | Galenicum Health S.L. | Pharmaceutical compositions containing an active agent |
JP7017938B2 (en) * | 2018-01-15 | 2022-02-09 | 森下仁丹株式会社 | 3-oxo-4-azaandrost-1-ene-17-carboxylic acid derivative-containing preparation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516768A (en) * | 1990-03-16 | 1996-05-14 | Smithkline Beecham Corporation | Uncompetitive inhibition of steroid and 5α-reductose |
US5300294A (en) * | 1990-06-27 | 1994-04-05 | Smithkline Beecham Corporation | Method of treating prostatic adenocarcinoma |
TW408127B (en) * | 1993-09-17 | 2000-10-11 | Glaxo Inc | Androstenones |
WO1997011702A1 (en) * | 1995-09-27 | 1997-04-03 | Merck & Co., Inc. | Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors |
AU5369198A (en) * | 1996-12-09 | 1998-07-03 | Merck & Co., Inc. | Methods and compositions for preventing and treating bone loss |
-
1997
- 1997-08-19 GB GBGB9717444.5A patent/GB9717444D0/en active Pending
-
1998
- 1998-08-17 WO PCT/EP1998/005192 patent/WO1999008684A2/en not_active Application Discontinuation
- 1998-08-17 EP EP98941422A patent/EP1005346A2/en not_active Withdrawn
- 1998-08-17 CN CN98806379A patent/CN1263466A/en active Pending
- 1998-08-17 KR KR19997012115A patent/KR20010014079A/en not_active Application Discontinuation
- 1998-08-17 BR BR9810285-0A patent/BR9810285A/en not_active Application Discontinuation
- 1998-08-17 AU AU89796/98A patent/AU8979698A/en not_active Abandoned
- 1998-08-17 TR TR1999/03211T patent/TR199903211T2/en unknown
- 1998-08-17 CA CA002295023A patent/CA2295023A1/en not_active Abandoned
- 1998-08-17 JP JP51280799A patent/JP2002511100A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1999008684A3 (en) | 1999-06-10 |
WO1999008684A2 (en) | 1999-02-25 |
CN1263466A (en) | 2000-08-16 |
KR20010014079A (en) | 2001-02-26 |
GB9717444D0 (en) | 1997-10-22 |
CA2295023A1 (en) | 1999-02-25 |
EP1005346A2 (en) | 2000-06-07 |
AU8979698A (en) | 1999-03-08 |
JP2002511100A (en) | 2002-04-09 |
BR9810285A (en) | 2000-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3484779D1 (en) | PHARMACEUTICAL AGENTS. | |
TR199903211T2 (en) | Solutions containing azasteroids. | |
TR200000517T2 (en) | Pharmaceutical composition for the combination of piperidinoalkanol-Congestion reducer. | |
TR200101333T2 (en) | Pharmaceutical composition for modified release of an insulin sensitiser and another anti-diabetic agent. | |
NZ280610A (en) | Soft gelatin-like pharmaceutical carrier: gelled polyethylene glycol and dispersed active agent | |
PL341054A1 (en) | Novel suppositiories containing an active compound being unstable in acid environments | |
FR2760193B1 (en) | LIPIDS AND COMPLEXES OF CATIONIC LIPIDS AND ACTIVE SUBSTANCES, IN PARTICULAR FOR THE TRANSFECTION OF CELLS | |
ID26340A (en) | DOUBLE CAPSULES WITH THE USE OF ACTIVE MATERIALS IN VARIOUS TYPES OF TREATMENTS | |
TR200100931T2 (en) | New sustained release oral formulations | |
IL128801A (en) | Pharmaceutical composition comprising a substance inhibiting no synthase | |
PL327767A1 (en) | Drugs containing known auxiliary substances and an active substance | |
ES2162922T3 (en) | COMPOSITION FOR COLONIC ADMINISTRATION OF MEDICINES. | |
TR200200982T2 (en) | Pharmaceutical composition compositions. | |
DE69813602T2 (en) | VENLAFAX-CONTAINING MEDICINE WITH EXTENDED ACTIVE SUBSTANCE | |
TR199902175T2 (en) | Swallowing tablet containing paracetamol. | |
TR199901413T2 (en) | New treatment for joint inflammation. | |
TR199903209T2 (en) | Pharmaceutical composition. | |
TR200101337T2 (en) | Pharmaceutical composition and use for modified release insulin sensitiser. | |
SE9803272D0 (en) | A drug for cell regeneration | |
DE3070184D1 (en) | Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them | |
DE3068074D1 (en) | Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them | |
DE69713505T2 (en) | MEDICAMENT CONTAINING MIZOLASTIN WITH DELAYED ACTIVE SUBSTANCE | |
DE3067790D1 (en) | Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them | |
AR019331A2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING AN INSULIN SENSITIZER AND AN INSULIN SECRETAGOG. | |
EE04347B1 (en) | 8-Azabicyclo [3.2.1] octane-3-methanamine derivatives, medicament and pharmaceutical composition containing them |